News Daily News FDA Advisors Decline to Recommend Vernakalant Approval Shelley Wood December 11, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019